AU770580B2 - Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia - Google Patents

Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia Download PDF

Info

Publication number
AU770580B2
AU770580B2 AU13857/00A AU1385700A AU770580B2 AU 770580 B2 AU770580 B2 AU 770580B2 AU 13857/00 A AU13857/00 A AU 13857/00A AU 1385700 A AU1385700 A AU 1385700A AU 770580 B2 AU770580 B2 AU 770580B2
Authority
AU
Australia
Prior art keywords
treatment
dyspeptic symptoms
addition salt
prucalopride
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU13857/00A
Other languages
English (en)
Other versions
AU1385700A (en
Inventor
Joannes Adrianus Jacobus Schuurkes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU1385700A publication Critical patent/AU1385700A/en
Application granted granted Critical
Publication of AU770580B2 publication Critical patent/AU770580B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU13857/00A 1998-11-23 1999-11-16 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia Ceased AU770580B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98203943 1998-11-23
EP98203943 1998-11-23
PCT/EP1999/009048 WO2000030640A1 (fr) 1998-11-23 1999-11-16 Utilisation de prucalopride dans la production d'un medicament de traitement de la dyspepsie

Publications (2)

Publication Number Publication Date
AU1385700A AU1385700A (en) 2000-06-13
AU770580B2 true AU770580B2 (en) 2004-02-26

Family

ID=8234369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13857/00A Ceased AU770580B2 (en) 1998-11-23 1999-11-16 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Country Status (7)

Country Link
EP (1) EP1135130A1 (fr)
JP (1) JP2002530334A (fr)
KR (1) KR20010080025A (fr)
AU (1) AU770580B2 (fr)
CA (1) CA2352278A1 (fr)
NZ (1) NZ511117A (fr)
WO (1) WO2000030640A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
DE60300683T2 (de) 2002-01-16 2006-04-27 Janssen Pharmaceutica N.V. Prucaloprid-n-oxid
KR20050002925A (ko) * 2002-04-08 2005-01-10 제리아 신야쿠 고교 가부시키 가이샤 위 음식물 수용능 장해 치료약

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445862A2 (fr) * 1990-03-06 1991-09-11 Janssen Pharmaceutica N.V. Dérivés de la N-(4-pipéridinyl-)-dihydrobenzofurane- ou de ca dihydro-2H-benzopyrannecarboxamide
WO1996016060A1 (fr) * 1994-11-24 1996-05-30 Janssen Pharmaceutica N.V. Benzamide peristaltique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445862A2 (fr) * 1990-03-06 1991-09-11 Janssen Pharmaceutica N.V. Dérivés de la N-(4-pipéridinyl-)-dihydrobenzofurane- ou de ca dihydro-2H-benzopyrannecarboxamide
WO1996016060A1 (fr) * 1994-11-24 1996-05-30 Janssen Pharmaceutica N.V. Benzamide peristaltique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STEADMAN'S MEDICAL DICTIONARY 24TH EDITION PAGE 434 *

Also Published As

Publication number Publication date
AU1385700A (en) 2000-06-13
EP1135130A1 (fr) 2001-09-26
CA2352278A1 (fr) 2000-06-02
JP2002530334A (ja) 2002-09-17
KR20010080025A (ko) 2001-08-22
NZ511117A (en) 2002-11-26
WO2000030640A1 (fr) 2000-06-02

Similar Documents

Publication Publication Date Title
RU2159614C2 (ru) Высушенные замораживанием композиции ондансетрона и способ лечения млекопитающих
Leung et al. Weight management and current options in pharmacotherapy: orlistat and sibutramine
JP3977724B2 (ja) 医薬組成物
KR101188746B1 (ko) 에스-알릴-엘-시스테인을 유효성분으로 포함하는 위장질환 예방 또는 치료용 조성물
CA3012675C (fr) Une composition pharmaceutique destinee a la prevention de l'obesite induite par la diete
JP2014507374A (ja) 金銀花抽出物を含む逆流性食道炎治療または予防用薬学組成物
JP2017515499A (ja) 血糖値を低下させ、体重管理をするための健康食品組成物
CA2166730A1 (fr) Combinaisons d'un agent de motilite gastro-intestinal et d'un antagoniste des recepteurs h2
WO2021195020A1 (fr) Méthodes et compositions pour prévenir et traiter la fibrose résultant d'une infection à coronavirus
JP2007051134A (ja) Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
CA2311423C (fr) Methode pour le traitement de l'hyperlipidemie
JP2022532643A (ja) 肝機能改善活性を示す菌株及びその用途
US20200038322A1 (en) Colchicine drug-to-drug interactions
ITMI20070517A1 (it) Composizione solida farmaceutica contenente una associazione di un agente regolatore della motilita' intestinale ed un antiflatulente.
AU770580B2 (en) Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
CN103813792B (zh) 用于治疗膀胱过度活动症的索利那新和唾液刺激剂的组合
Ali et al. Role of prucalopride in treating functional constipation and gastroparesis: a systemic review
NO320733B1 (no) Anvendelse av noytrofil-funksjons-inhibitorer for fremstilling av preparater for medisinsk behandling
JP6112767B2 (ja) 血液中の尿酸値を低下させるための組成物
EP1175906B1 (fr) Améliorateurs du flux sanguin et préventives de la thrombose ou remèdes qui comprennent de la glucosamine
Quigley Pharmacotherapy of gastroparesis
KR20070112546A (ko) 구기자 추출물을 포함하는 식품조성물
CN113840633B (zh) 凝结芽孢杆菌和枯草芽孢杆菌用于预防和治疗功能性胃肠道病症
JP6795662B2 (ja) ウロプラキン発現促進剤
WO2012060594A2 (fr) Composition anti-inflammatoire contenant un composé thiourée et un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)